Business Segments and Geographic Areas

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Business Segments and Geographic Areas

Business Segments and Geographic Areas

We are accounting and reporting for our business as a single operating segment entity engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Our chief operating decision maker (the CEO) evaluates the various global product portfolios on a net sales basis and evaluates profitability, investment, cash flow metrics and allocates resources on a consolidated worldwide basis due to shared infrastructure and resources. Our product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and fees related to sales representation, promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. These product lines' net sales and primary geographic market where the products are sold, are as follows for the years ended December 31, 2022, 2021 and 2020:

	2022
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	173,176	$	405,777	$	578,953
Europe, Middle East & Africa	113,649		84,288		197,937
Asia Pacific	103,353		59,124		162,477
Americas (excluding the United States)	71,350		34,755		106,105
Total sales from contracts with customers	$	461,528	$	583,944	$	1,045,472

	2021
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	158,553	$	393,980	$	552,533
Europe, Middle East & Africa	108,457		81,238		189,695
Asia Pacific	107,590		63,628		171,218
Americas (excluding the United States)	63,824		33,365		97,189
Total sales from contracts with customers	$	438,424	$	572,211	$	1,010,635

	2020
	Orthopedic Surgery		General Surgery		Total
Primary Geographic Markets
United States	$	139,715	$	342,349	$	482,064
Europe, Middle East & Africa	90,998		70,086		161,084
Asia Pacific	93,636		46,961		140,597
Americas (excluding the United States)	50,356		28,358		78,714
Total sales from contracts with customers	$	374,705	$	487,754	$	862,459

Sales are attributed to countries based on the location of the customer. There were no significant investments in long-lived assets located outside the United States at December 31, 2022 and 2021.  No single customer represented over 10% of our consolidated net sales for the years ended December 31, 2022, 2021 and 2020.